Mechanistic Target of Rapamycin and Megalencephaly: Novel Research Strategies for Therapeutic Discovery
Open Access
- 26 February 2026
- journal article
- Published by SAGE Publications in Epilepsy Currents
Abstract
Megalencephaly (ME) is a malformation of cortical development defined by an enlarged brain. Individuals with ME often suffer from drug resistant epilepsy, intellectual disability, and autism spectrum disorder. Several clinical ME subtypes result from pathogenic variants in mTOR pathway genes (MPG) which cause diffuse brain overgrowth likely as a consequence of hyperactive mechanistic target of rapamycin (mTOR) signaling during brain development. Unfortunately, resected surgical or post-mortem ME brain tissue specimens are not widely available, and thus, there is only limited understanding of the histopathology of MPG associated ME. Thus, research strategies including new mouse models and human cerebral organoids have been developed to study the developmental pathogenesis of ME linked to MPG variants. These model systems provide a platform to study the mechanisms leading to brain overgrowth in ME as well as the establishment of the epileptic network. Perhaps most compelling, pre-clinical research approaches in ME models may pave the way for therapeutic development that could be deployed in utero to prevent ME formation.Keywords
Funding Information
- Whitney Parker (NINDS K08NS140393)
- Philip Iffland (NINDS R01NS131223)
- Peter B. Crino (NINDS R37 NS125632 1)
This publication has 51 references indexed in Scilit:
- Megalencephaly and hemimegalencephaly: Breakthroughs in molecular etiologyAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2014
- Mutations in KPTN Cause Macrocephaly, Neurodevelopmental Delay, and SeizuresThe American Journal of Human Genetics, 2014
- Modeling Transformations of Neurodevelopmental Sequences across Mammalian SpeciesThe Journal of Neuroscience, 2013
- Rapamycin Prevents Seizures After Depletion of STRADA in a Rare Neurodevelopmental DisorderScience Translational Medicine, 2013
- Prenatal Rapamycin Results in Early and Late Behavioral Abnormalities in Wildtype C57Bl/6 MiceBehavior Genetics, 2012
- Everolimus for Tumor Recurrence After Surgical Resection for Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis ComplexJournal of Child Neurology, 2012
- mTOR SignalingCold Spring Harbor Perspectives in Biology, 2011
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous SclerosisNew England Journal of Medicine, 2010
- STRADα deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and miceJournal of Clinical Investigation, 2010
- Polyhydramnios, megalencephaly and symptomatic epilepsy caused by a homozygous 7-kilobase deletion in LYK5Brain, 2007